- Home
- AMAL vs ORKA Comparison
AMAL vs ORKA Comparison
Compare AMAL & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMAL
- ORKA
- Stock Information
- Founded
- AMAL 1923
- ORKA 2004
- Country
- AMAL United States
- ORKA United States
- Employees
- AMAL N/A
- ORKA N/A
- Industry
- AMAL Commercial Banks
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMAL Finance
- ORKA Health Care
- Exchange
- AMAL Nasdaq
- ORKA Nasdaq
- Market Cap
- AMAL 1.0B
- ORKA 1.0B
- IPO Year
- AMAL 2018
- ORKA N/A
- Fundamental
- Price
- AMAL $33.17
- ORKA $19.97
- Analyst Decision
- AMAL Buy
- ORKA Strong Buy
- Analyst Count
- AMAL 4
- ORKA 6
- Target Price
- AMAL $37.13
- ORKA $43.60
- AVG Volume (30 Days)
- AMAL 146.4K
- ORKA 394.7K
- Earning Date
- AMAL 01-23-2025
- ORKA 02-15-2025
- Dividend Yield
- AMAL 1.45%
- ORKA N/A
- EPS Growth
- AMAL 16.43
- ORKA N/A
- EPS
- AMAL 3.39
- ORKA N/A
- Revenue
- AMAL $303,032,000.00
- ORKA N/A
- Revenue This Year
- AMAL N/A
- ORKA N/A
- Revenue Next Year
- AMAL $4.24
- ORKA N/A
- P/E Ratio
- AMAL $9.80
- ORKA N/A
- Revenue Growth
- AMAL 12.76
- ORKA N/A
- 52 Week Low
- AMAL $21.33
- ORKA $17.64
- 52 Week High
- AMAL $38.19
- ORKA $53.88
- Technical
- Relative Strength Index (RSI)
- AMAL 36.43
- ORKA N/A
- Support Level
- AMAL $33.05
- ORKA N/A
- Resistance Level
- AMAL $34.20
- ORKA N/A
- Average True Range (ATR)
- AMAL 0.94
- ORKA 0.00
- MACD
- AMAL -0.15
- ORKA 0.00
- Stochastic Oscillator
- AMAL 22.94
- ORKA 0.00
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers a range of products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.